Compare Stocks

→ “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LQDA Liquidia	$12.37 -1.4%	$14.60	$5.71 ▼ $16.99	$940.47M	0.16	947,393 shs	626,497 shs
MOTS Motus GI	$0.09 +10.4%	$0.50	$0.05 ▼ $23.40	$428K	1.3	1.37 million shs	16,871 shs
PDEX Pro-Dex	$18.40 -0.5%	$17.65	$14.51 ▼ $22.99	$64.58M	0.6	7,889 shs	3,723 shs

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LQDA Liquidia	-3.09%	-9.45%	-19.91%	+4.85%	+87.31%
MOTS Motus GI	+10.00%	+1.32%	-83.26%	-91.78%	-99.37%
PDEX Pro-Dex	-1.33%	+1.31%	+7.37%	-14.15%	+15.99%

“The Biggest Bubble of All Time” – Here’s What to Do. (Ad)

Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.

Just click here.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LQDA Liquidia	2.4195 of 5 stars	3.3	1.0	0.0	0.0	2.7	4.2	0.6
MOTS Motus GI	1.1323 of 5 stars	3.5	3.0	0.0	0.0	0.6	0.0	0.6
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LQDA Liquidia	2.60	Moderate Buy	$21.00	69.77% Upside
MOTS Motus GI	3.00	Buy	$28.88	33,870.59% Upside
PDEX Pro-Dex	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest MOTS, LQDA, and PDEX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	LQDA Liquidia	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$28.00
4/1/2024	LQDA Liquidia	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$28.00
3/14/2024	LQDA Liquidia	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$16.00 ➝ $32.00
3/13/2024	LQDA Liquidia	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$28.00
2/21/2024	LQDA Liquidia	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$28.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LQDA Liquidia	$17.49M	53.78	N/A	N/A	$0.73 per share	16.95
MOTS Motus GI	$319K	1.34	N/A	N/A	$1.74 per share	0.05
PDEX Pro-Dex	$46.09M	1.40	$2.20 per share	8.37	$8.91 per share	2.07

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LQDA Liquidia	-$78.50M	-$1.20	N/A	N/A	N/A	-448.89%	-132.16%	-65.35%	5/2/2024 (Estimated)
MOTS Motus GI	-$12.87M	-$28.55	N/A	∞	N/A	-4,033.54%	N/A	-110.70%	5/8/2024 (Estimated)
PDEX Pro-Dex	$7.07M	$0.75	24.53	∞	N/A	5.59%	8.97%	5.40%	5/2/2024 (Estimated)

Latest MOTS, LQDA, and PDEX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
3/18/2024	Q4 2023	MOTS Motus GI	N/A	-$4.13	-$4.13	-$3.78	N/A	$0.06 million
3/13/2024	Q4 2023	LQDA Liquidia	-$0.23	-$0.42	-$0.19	-$0.42	$5.29 million	$4.53 million
2/8/2024	Q2 2024	PDEX Pro-Dex	N/A	$0.14	+$0.14	$0.14	N/A	$12.59 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LQDA Liquidia	N/A	N/A	N/A	N/A	N/A
MOTS Motus GI	N/A	N/A	N/A	N/A	N/A
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LQDA Liquidia	N/A	4.85	4.85
MOTS Motus GI	0.46	1.76	1.69
PDEX Pro-Dex	0.26	3.66	2.16

Ownership

Institutional Ownership

Company	Institutional Ownership
LQDA Liquidia	64.54%
MOTS Motus GI	20.06%
PDEX Pro-Dex	15.28%

Insider Ownership

Company	Insider Ownership
LQDA Liquidia	31.60%
MOTS Motus GI	1.57%
PDEX Pro-Dex	42.60%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
LQDA Liquidia	145	76.03 million	52.00 million	Optionable
MOTS Motus GI	15	5.03 million	4.95 million	Not Optionable
PDEX Pro-Dex	145	3.51 million	2.02 million	Not Optionable

MOTS, LQDA, and PDEX Headlines

Source	Headline
	What is Samsung DeX and how does it work? msn.com - April 23 at 11:18 AM
	Pro-Dex Inc. (co) money.usnews.com - April 19 at 10:51 AM
	Pro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Decrease in Short Interest marketbeat.com - April 13 at 11:20 AM
	Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200-Day Moving Average of $17.72 marketbeat.com - April 11 at 3:14 AM
	AutoPro X accessory will bring Samsung DeX to your vehicle msn.com - April 9 at 10:27 AM
	Vicarious Surgical Stock (NYSE:RBOT), Quotes and News Summary benzinga.com - April 2 at 10:06 PM
	Monogram Orthopaedics reports FY results seekingalpha.com - March 15 at 3:03 PM
	The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence finance.yahoo.com - February 22 at 2:16 PM
	Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results finance.yahoo.com - February 8 at 7:45 PM
	Pro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five years finance.yahoo.com - January 26 at 7:04 PM
	Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health? finance.yahoo.com - December 30 at 4:00 PM
	Dex Carvey Dies: Comedian Son Of Dana Carvey Was 32 deadline.com - November 22 at 4:30 AM
	PowerDEX Launches: CEX Performance Meets DEX Freedom coinspeaker.com - November 21 at 4:16 PM
	Here’s Why You Should Consider Buying Pro-Dex (PDEX) Shares finance.yahoo.com - November 14 at 2:04 AM
	Pro-Dex Inc PDEX morningstar.com - November 10 at 12:39 PM
	Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results finance.yahoo.com - November 2 at 6:52 PM
	Pro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000 finance.yahoo.com - November 2 at 6:52 PM
	Stock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast finanznachrichten.de - October 26 at 10:18 AM
	Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast finance.yahoo.com - October 26 at 10:18 AM
	Pro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year Results finance.yahoo.com - October 15 at 12:00 AM
	Pro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year Results finance.yahoo.com - October 13 at 7:19 PM
	North American Morning Briefing: S&P 500 Futures -2- morningstar.com - October 4 at 8:12 AM
	Pro-Dex's (NASDAQ:PDEX) Returns Have Hit A Wall finance.yahoo.com - August 7 at 7:33 AM
	At US$18.26, Is It Time To Put Pro-Dex, Inc. (NASDAQ:PDEX) On Your Watch List? finance.yahoo.com - June 29 at 1:37 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Liquidia

NASDAQ:LQDA

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Motus GI

NASDAQ:MOTS

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Pro-Dex

NASDAQ:PDEX

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial